|
Market Cap (17-May) $18,062,432 (1,390th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 0 |
Shortsold (21-Feb) 50,867 (0.01%) (619th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.06 |
AC8 released this announcement to the ASX on 14 October 2021, 9:49. The announcement is not marked as price sensitive, and is 20 page(s) in length and 472.72kb in size.
You can view all announcements from AC8 and see how they appear on a price chart on the announcements page.
At the date of this announcement, AC8 was 0.080% short sold according to ASIC data. It was ranked the 470th most shorted stock on the ASX. It remains ranked 619th as of the latest reported data (21 February 2022).
| Other Recent Announcements from AC8 | |
|---|---|
| Final Director's Interest Notice - C. Mews | 29 June 2023, 9:44 |
| Initial Director's Interest Notice - B. Mitchell | 29 June 2023, 9:44 |
| Appointment of Independent Non-Executive Director | 29 June 2023, 9:19 |
| Notice of Annual General Meeting/Proxy Form | 14 October 2021, 9:49 |
| AusCann Completes US Safety Study for DermaCann Registration | 13 October 2021, 9:39 |
| AusCann to Accelerate Human Drug Development Program | 21 September 2021, 9:15 |
| AusCann Appoints US Advisors to Advance CPAT-01 FDA Program | 9 September 2021, 8:20 |
You must be logged in to post a reply.
AusCann Group Holdings Ltd 